Clinical Trial Update: The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for NPC-06 evaluating the safety, efficacy, and pharmacokinetics of fosphenytoin in epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• fosphenytoin (fosphenytoin)

Snippet

Sponsor: Nobelpharma | Conditions: Epilepsy | Phase 3 | Status: COMPLETED